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Abstract
Infectious diseases of poverty (IDoP) disproportionately affect the poorest population in the world and contribute to a
cycle of poverty as a result of decreased productivity ensuing from long-term illness, disability, and social stigma. In
2010, the global deaths from HIV/AIDS have increased to 1.5 million and malaria mortality rose to 1.17 million. Mortality
from neglected tropical diseases rose to 152,000, while tuberculosis killed 1.2 million people that same year. Substantial
regional variations exist in the distribution of these diseases as they are primarily concentrated in rural areas of
Sub-Saharan Africa, Asia, and Latin America, with geographic overlap and high levels of co-infection. Evidence-based
interventions exist to prevent and control these diseases, however, the coverage still remains low with an emerging
challenge of antimicrobial resistance. Therefore, community-based delivery platforms are increasingly being advocated
to ensure sustainability and combat co-infections.
Because of the high morbidity and mortality burden of these diseases, especially in resource-poor settings, it is
imperative to conduct a systematic review to identify strategies to prevent and control these diseases. Therefore, we
attempted to evaluate the effectiveness of one of these strategies, that is community-based delivery for the prevention
and treatment of IDoP. In this paper, we describe the burden, epidemiology, and potential interventions for IDoP. In
subsequent papers of this series, we describe the analytical framework and the methodology used to guide the
systematic reviews, and report the findings and interpretations of our analyses of the impact of
community-based strategies on individual IDoPs.
Keywords: Infectious diseases of poverty, Neglected tropical diseases malaria, HIV/AIDS, Tuberculosis,
Community-based interventions, Community platforms, Community-health workers
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Introduction
The Global Burden of Disease Study 2010 reports an in-
crease of 111,000 deaths globally attributable to malaria
and neglected tropical diseases (NTDs) (including
chagas, leishmaniasis, African trypanosomiasis, schisto-
somiasis, cysticercosis, echinococcosis, dengue, rabies,
ascariasis, as well as other NTDs) in the last two
decades, with substantial regional variations and Sub-
Saharan Africa accountable for most of the premature
mortalities [1,2]. In 2010, the global deaths from human
immunodeficiency virus (HIV)/ acquired immunodefi-
ciency syndrome (AIDS) have increased to 1.5 million,
and malaria mortality rose to 1.17 million. Mortality
from NTDs rose to 152,000, while tuberculosis (TB)
killed 1.2 million people that same year [2]. The United
Nations (UN) Millennium Declaration which translated
into the Millennium Development Goals (MDGs)
underscored the need to combat HIV/AIDS, malaria,
and TB, while other infectious diseases including most
of the tropical diseases collectively termed as NTDs
have slipped into a ‘neglected’ category, by default [3-6].
NTDs along with HIV, TB, and malaria are collectively
referred to as ‘infectious diseases of poverty’ (IDoPs),
and these are primarily concentrated in rural areas of
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Sub-Saharan Africa, Asia, and Latin America, with geo-
graphic overlap resulting in high levels of co-infection
[7-11]. It is estimated that more than 90% of the total
impact as a result of death and disability caused by
neglected diseases occurs in Sub-Saharan Africa [12].
IDoP disproportionately affect the poorest populations
in the world and contribute to a cycle of poverty as a re-
sult of decreased productivity ensuing from long-term ill-
ness, disability, and social stigma [3,5]. The affected
populations usually have fewer material, physical, and fi-
nancial resources to draw from and limited or no access
to integrated health care, prevention tools and medica-
tions, thus resulting in the most severe adverse impacts.
Various social determinants also compound the issue and
these include gender dilemmas, unemployment, illiteracy,
poor nutrition, indoor air pollution, political instability,
and lack of access to proper sanitation and health educa-
tion, among others [3]. The socioeconomic and physical
conditions of those living in poverty create environments
that facilitate the transmission of vectors and pathogens
consequently leading to long-term illness that further ex-
acerbates poverty by diminishing productivity. Further-
more, global attention and resources have been focused
on HIV/AIDS, malaria, and TB as these are specifically
outlined in MDG 6, while NTDs have consequently been
relegated into the group of “other diseases”, and until
2010, NTDs represented only 0.6% of the total inter-
national development assistance for health [13] despite af-
fecting as many poor people as the big three diseases.
A large proportion of these infectious diseases in low-
middle- income countries (LMICs) are entirely avoidable
or treatable with existing medicines or interventions
[14]. Effective and simple interventions to prevent and
treat these infectious diseases exist but their delivery to
affected populations has proven very difficult due to
weak health system infrastructure in many developing
countries, thus the need to shift the focus from institu-
tional care delivery to community platforms for im-
proved accessibility. This paper aims to review the
disease burden, distribution, existing interventions, and
coverage for the prevention and control of IDoP (includ-
ing NTDs, malaria, TB, and HIV/AIDS), and is followed
by a series of papers evaluating the effectiveness of com-
munity delivered interventions for the prevention and
control of each IDoP.
Review: disease distribution, burden, and consequences
NTD are a group of 17 bacterial, parasitic protozoal,
and viral infections (including dengue, rabies, chagas
disease, human African trypanosomiasis, leishmaniasis,
cysticercosis/taeniasis, dracunculiasis, echinococcosis,
foodborne trematodiases, treponematoses, lymphatic fil-
ariasis, onchocerciasis, schistosomiasis, soil-transmitted
helminthiases, buruli ulcer, leprosy, trachoma, and yaws)
that are chronic and particularly endemic amongst the
population in tropical and subtropical regions (Figure 1)
[15]. The most common NTDs are a group of helminthic
infections affecting one-third of the almost three billion
people living on less than USD $2 per day in developing
regions of Sub-Saharan Africa, Asia, and the Americas
[8,16].
In 2012, malaria was responsible for over 1.1 million
deaths globally [2] and was endemic in 104 countries with
substantial geographic disparities. Around 81% of the mal-
aria incidence and 91% of the malaria deaths in 2010 oc-
curred in Africa and 86% involved children under five years
of age [17]. A number of factors account for the malaria
burden in developing countries, which include climate
change, infrastructure, emerging drug and insecticide resist-
ance, massive population and demographic shifts, and costs
of containment and therapy. Malaria transmission also
greatly depends on climatic conditions such as rainfall
Figure 1 Global overlap of the six most common NTDs.
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patterns, temperature, and humidity. In many endemic
areas, transmission is seasonal, with peaks during and just
after the rainy season. However, the past decade has seen
tremendous expansion in malaria financing and consequent
coverage of interventions. Approximately half of countries
with ongoing malaria transmission are on track to meet the
World Health Assembly (WHA) and Roll Back Malaria
(RBM) targets to achieve a 75% reduction in malaria cases
by 2015, as compared to those in 2000 [18].
More than 65 million people have been infected with
HIV and 30 million people have died due to AIDS-
related causes since the emergence of AIDS in 1981
[19]. In 2010, HIV was responsible for approximately 1.5
million deaths [2]. It has an extremely uneven geograph-
ical distribution, with Sub-Saharan Africa bearing more
than two-thirds of the global burden [20], followed by
Asia and the Pacific, where nearly 372,000 people be-
came newly infected in 2011 [21]. Of the 34 million
people living with HIV as of 2011, 3.3 million were chil-
dren under 15 years and 16.7 million were women [21].
Adolescents are also vulnerable as an estimated 2.1 mil-
lion adolescents (aged 10–19 years) were living with
HIV in 2012 in LMICs, with the prevalence among
young women twice as high as that among young men
throughout Sub-Saharan Africa [22]. Progress has been
made on some fronts. The UNAIDS World AIDS Day
Report 2012 reported a 50% reduction in HIV incidence
in 25 LMICs between 2001 and 2011 [21], while in Sub-
Saharan Africa, the number of newly infected children
declined by 24% between 2009 and 2011 [20]. With this
burden of HIV, the susceptibility of co-infection with
leishmaniasis and TB also rises, and despite proper
treatment, relapse is common and often results in death
[23].
TB is the second greatest killer worldwide due to a
single infectious agent after HIV/AIDS. In 2010, 1.2 mil-
lion deaths were attributable to TB [2]. Over 95% of TB
deaths occur in LMICs with the highest burden in Asia
and Africa. The African region has 24% of the world’s
TB cases and the highest rates of cases and deaths per
capita, while India and China together account for al-
most 40% of the world’s TB burden [24]. There is also
the emerging issue of multi-drug resistant TB (MDR-
TB), which is rising and reached 60,000 in the 27 high
MDR-TB burden countries worldwide in 2011 [24]. Al-
though the MDG target to halt and reverse the TB epi-
demic by 2015 is already achieved, the disease burden
remains enormous with resurgence in many areas due
to HIV/AIDS. An estimated 13% of the TB cases in
2011 were co-infected with HIV and 430,000 deaths
were among the HIV-positive population [24].
As a group, IDoP are amongst the top ten causes of
disability-adjusted years (DALYs) (see Table 1). They can
lead to burdensome health consequences that include
blindness due to onchocerciasis and trachoma, and dis-
figurement from Lymphatic filariasis (LF), leishmaniasis,
leprosy and buruli ulcer, leading to severe economic
costs [25]. Schistosomiasis can result in severe organ
pathology, anemia, malnutrition, and can also increase
the risk of HIV. Repeated infection with trachoma can
lead to scarring of the inside of the eyelid such that it
turns inward, resulting in trichiasis and scar of the cornea.
If untreated, irreversible corneal opacities are formed and
blindness ensues. Ascariasis, trichuriasis, schistosomiasis,
hookworms, malaria, and TB can lead to malnutrition and
anemia, which is of particular concern for young children
and pregnant women who are especially prone to the ad-
verse health consequences of undernutrition. Most of
these infections affect children and young adults leading
to the loss of their most productive years, and some of
these diseases can be fatal if left untreated [6]. Infections
of severe intensity can impair physical growth and cogni-
tive development and are a cause of micronutrient defi-
ciencies leading to poor school performance and
absenteeism in children, reduced work productivity in
Table 1 Estimated number of disability-adjusted life years
(DALYs) (in thousands) by IDoP
Infectious diseases of poverty Estimated DALYs
(in thousands)
Neglected tropical diseases
Viral: Dengue 1, 243
Rabies 2, 297
Protozoan: Human African trypanosomiasis 1, 346
Chagas disease 499
Leishmaniasis 3, 754
Helminth: Cysticercosis/Taeniasis 503
Dracunculiasis –
Echinococcosis 600
Food borne trematodiasis 665
Lymphatic filariasis 2, 740
Onchocerciasis 564
Schistosomiasis 3, 971
Ascariasis 1, 254
Trichuriasis 630
Hookworm disease 3, 159
Bacterial: Buruli ulcer –
Leprosy 215
Trachoma 308
Yaws –
Tuberculosis 42,240
HIV/AIDS 95,226
Malaria 55,414
Source: WHO. Disease Burden: DALY Estimates 2011 and Global Burden of
Diseases 2010.
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adults, and adverse pregnancy outcomes [26]. Malaria
during pregnancy may lead to severe disease, spontaneous
abortions, preterm birth, low birth weight, and anemia.
In addition to the grave health consequences, this group
of diseases also leads to huge economic costs for both the
individual and society. Leishmaniasis results in approxi-
mately USD $1.3 billion/years lost in productivity, while
for trachoma the loss in productivity is estimated at USD
$2.9 billion [27]. In India, the average total economic bur-
den for dengue fever is approximately USD $29.3 million,
and schistosomiasis in the Philippines results in 45.4 days
off-work lost per infected person/year [23]. Direct costs
associated with malaria-encompassing illnesses, treatment,
and premature deaths have been estimated to be at least
USD $12 billion per year, however, the costs are often
more than that in terms of lost economic growth [27]. Con-
versely, controlling these diseases has the potential to in-
crease productivity as deworming against soil-transmitted
helminthiasis (STH) in Kenya has shown to increase the
present wages by more than USD $40 per treated person,
with a benefit-to-cost ratio of 100 [28].
Interventions and coverage
The World Health Organization (WHO) promotes the
use of five public health strategies to control, eliminate,
and eradicate NTDs. These include preventive chemo-
therapy; innovative and intensified disease-management;
vector control and pesticide management; provision of
safe drinking water, basic sanitation and hygiene, and edu-
cation; and veterinary public health services [29]. Mass
drug administration (MDA) has been a major approach to
combat helminthiasis including ascariasis, trichuriasis,
hookworm, schistosomiasis, LF, onchocerciasis, and trach-
oma in developing countries [30]. There is evidence sug-
gesting significant benefits of treating diagnosed cases
[31,32], and these medicines are not only effective but also
cost efficient. A USD $0.50 package containing several in-
expensive and safe drugs can treat more than 15 types of
neglected parasitic infections [33].
The WHO recommends periodic preventive treatment
with anthelmintics for all at-risk people living in endemic
areas to reduce morbidity by reducing the worm burden.
Large-scale and successful control activities implemented
during 2001–2010 demonstrate the feasibility of mass
deworming, and these experiences have informed the de-
velopment of tools to facilitate its implementation [34]. Of
the 123 countries requiring preventive chemotherapy, 40
require interventions for three or more diseases and 33 of
these 40 countries are in Africa [23,29]. About 1.9 billion
people require preventive chemotherapy for at least one
NTD; 55% of them require preventive treatment for one
or two diseases, and 45% require it for three or more dis-
eases [23,29]. However, by the end of 2010, only 25 coun-
tries had achieved at least one of the targets set for
delivering preventive chemotherapy for LF, onchocerciasis
or STH, and only five of these countries had reached the
targets for delivering preventive chemotherapy for three
or more diseases simultaneously [23,29]. Therefore, inter-
ventions need to be scaled-up considerably if targets set in
the WHA’s resolutions are to be met [29].
Key interventions recommended by the WHO to pre-
vent and control malaria include prompt and effective
treatment with artemisinin-based combination therapies;
the use of insecticide-treated nets (ITNs); and indoor re-
sidual spraying (IRS) with insecticide to control vector
mosquitoes. In the past decade, the percentage of house-
holds owning at least one ITN in Sub-Saharan Africa
reached an estimated 53% by 2011 and remained at 53%
in 2012. It must be noted however that this is greatly
challenged by the limited deliveries of ITNs and increas-
ing mosquito resistance to insecticides [18]. In 2011, the
proportion of pregnant women attending an antenatal
care clinic and receiving two doses of intermittent pre-
ventive treatment during pregnancy (IPTp) ranged from
30% to 57% in 2011, however, intermittent preventive
treatment for infants and seasonal malaria chemopre-
vention for children still await to be adopted by endemic
countries [18,35]. An emerging challenge arising due to
over diagnosis and treatment is the drug resistance to
artemisinins detected in four countries of the Greater
Mekong Subregion: Cambodia, Myanmar, Thailand, and
Vietnam [18]. More recently, the WHO has introduced
a new initiative, entitled “T3: Test, Treat and Track”. It
urges malaria-endemic countries and donors to move to-
wards universal access to diagnostic testing and antimal-
arial treatment to build robust control and surveillance
systems. The current recommendation of diagnostic
confirmation of malaria before treatment initiation was
adopted by 41 countries in the African region, however,
this practice attained less than 50% coverage in 2011
even in public health facilities [35].
Strategies for HIV prevention involve risk-reduction
through education and counseling. The WHO has recom-
mended key approaches which include condom use,
testing and counseling, male circumcision, preventive
antiretroviral therapy (ART), harm reduction for injecting
drug users, and elimination of mother-to-child transmis-
sion (MTCT) of HIV [36,37]. In 2012, 9.7 million people
in LMICs received ART (representing 61% of all who
were eligible), however, under the 2013 WHO guide-
lines, this treatment coverage represents only 34% of
the 28.3 million people eligible [22]. Although the
coverage of effective ART regimens in LMICs for pre-
venting MTCT was 57% in 2011, a lot is still desired to
eliminate it completely as a recent report suggested
that, on average, nearly half of all children newly
infected with HIV in the 20 African countries surveyed
were acquiring HIV during breastfeeding because of
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low ART coverage during this period. In 2012, 375,000
more pregnant women living with HIV received ART
medicines than in 2009 [38].
TB is preventable as well as curable, and its transmis-
sion could be prevented by prompt identification and
treatment of the infection. The WHO is working to dra-
matically reduce the burden of TB and halve TB deaths
and prevalence by 2015 through its Stop TB Strategy
and by supporting the Global Plan to Stop TB. Between
1995 and 2011, 51 million people were successfully
treated for TB in countries that had adopted the WHO
strategy, saving 20 million lives [24]. There has also been
progress in implementing collaborative TB/HIV activities
as recommended by the WHO in 2004 [24].
The changing care paradigm
A large proportion of infectious diseases in LMICs are en-
tirely avoidable or treatable with existing medicines or in-
terventions which are also highly cost effective, however,
their delivery to the affected populations has proven very
difficult due to weak health systems and infrastructures
[14]. Another major issue is access to and utilization of
health services, which has been a concern in LMICs, with
not enough progress being made on various health parame-
ters. Other impeding factors include gender discrimination,
low levels of female literacy, and lack of women empower-
ment; all of these prevent women from seeking care for
themselves and their children. Health care is also unafford-
able for many families due to economic barriers including
formal and informal healthcare fees, cost of medicines and
tests, cost of not working during hospitalization, travel,
food, and accommodation.
Effective delivery of proven interventions require a var-
iety of components ranging from training health workers,
effective use of epidemiological data, proper delivery of
safe medicines and commodities, accurate monitoring and
evaluation, and providing feedback to the community.
Successful implementation requires a positive interrelation
between programs for disease control and the health sys-
tem at large. Global health initiatives have created a com-
plex health system with an increasing number of actors
entering the field and implementing diverse health sys-
tems strategies [39]. These health system issues need to be
acknowledged and worked on [40]. Therefore, a combin-
ation of public health strategies is required to achieve con-
trol of each of these diseases and an integrated approach
to disease control and elimination is strongly advised es-
pecially in high-burden countries [29]. There are also wide
inequities in access to and utilization of healthcare
amongst the wealth quintiles. Poor children are more
likely to be exposed to health risks, and they have less re-
sistance to diseases because of undernutrition and other
hazards. These inequities are compounded by reduced ac-
cess to preventive and curative interventions [41].
Community-based interventions (CBIs) have the po-
tential to overcome the barriers of access and availability
and, if adequately equipped and supported by parallel
structures, can make a significant impact on reducing
the burden of IDoP [42-44]. However, a major issue is
the availability of a trained health force to scale-up these
interventions in population settings. According to a
2006 report by the WHO, 57 countries from Africa and
Asia are facing shortages of a healthcare workforce and
a total estimate of 4,250,000 workers are needed to fill
the gap [45]. For scaling-up these interventions, there is
a need to strengthen health systems [46], and also to de-
velop alternative cadres for task shifting from trained
healthcare workers to lay workers and from specialized
facilities to community-based delivery [47]. Many of the
interventions targeting infectious diseases have been ad-
ministered via community platforms through the com-
munity health workers (CHWs) who have received basic
training [48-50]. Although CHWs may not be able to re-
place the need for sophisticated healthcare delivery, they
can play an important role in providing access to health
care and services for the unreachable. Successful exam-
ples exist, for example, in Brazil, where CHWs provide
coverage to over 60 million people [51]. Ethiopia is
training about 30,000 workers with emphasis on mater-
nal and child health, HIV, and malaria. Other similar
programs are also being considered in countries such as
India, Ghana, and South Africa. Apart from providing
chemotherapy, CHWs can also play a major role in
imparting health education regarding general hygiene
and sanitation and intervene for vector control measures
within household and community settings. These com-
munity delivery strategies are not only effective but are
also cost efficient, and by training teachers and other
school personnel to administer anthelmintic drugs, costs
could be reduced by “piggy-backing” on existing pro-
grams in the educational sector [52]. In Ghana and
Tanzania, delivery of school-based targeted anthelmintic
treatment cost as little as US $0.03 per child, which is as
low as one-tenth of the estimated costs for vertical deliv-
ery [52].
Conclusion
In order to evaluate the effectiveness of CBIs, we devel-
oped an analytical framework and conducted systematic
reviews of the existing studies focusing on CBIs for pre-
vention and control of helminthic and non-helminthic
NTDs, malaria, TB, and HIV/AIDS compared to the rou-
tine healthcare delivery. For this review, we categorized
NTDs into helminthic and non-helminthic diseases, and
reported the findings accordingly in separate papers. Hel-
minthic diseases included soil-transmitted helminthia-
sis (ascariasis, hookworm, and trichuriasis) along with
schistosomiasis, lymphatic filariasis, onchocerciasis, and
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dracunculiasis. Non-helminthic diseases included den-
gue, African trypanosomiasis, chagas, leishmaniasis,
trachoma, leprosy, and buruli ulcer. In this series of
eight papers, we describe the analytical framework and
methodology used for the systematic reviews, and report
findings on the effectiveness of CBIs for the prevention
and control of helminthic NTDs, non-helminthic NTDs,
malaria, HIV/AIDS, and tuberculosis. In the final paper,
we propose a way forward.
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